CLINICAL_TRIALS
trial_result
· 2024-02-28
Clinical Trial Update: Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients [Phase 1, Phase 2]
Summary
A clinical trial update for Ficus septica leaf fraction used as a complementary therapy in stage IV breast cancer (Phase 1/Phase 2).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gadjah Mada University | Conditions: Breast Cancer Stage IV | Phase 1, Phase 2 | Status: UNKNOWN